🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 766559702 (prev. 766559603 )
- Market Cap
- Small Cap
- IPO
- 11/28/2000 · $7.00/share
Business: Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.
Notes: June 25, 2024 -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will effect a reverse stock split of its issued and outstanding shares of common stock at a ratio of 1-for-10 (the "Reverse Stock Split"), effective at 12:01 a.m. Eastern Time on Thursday, June 27, 2024. The company's common stock will begin trading on a post-split basis on The Nasdaq Global Select Market under the same symbol (RIGL) when the market opens on Thursday, June 27, 2024, with the new CUSIP number 766559702.
Company Contact
- CEO
- Raul R. Rodriguez
- CFO
- Dean Schorno
- Headquarters
- 611 Gateway Boulevard, Suite 900, South San Francisco, CA
- Phone
- 650-624-1100
- Fax
- 650-624-1101
- Investor Relations
- 650-624-1284 · ir@rigel.com